Skip to main content
SpringerLink
Log in

Urologic Cancer and the First Patterns of Metastasis

  • Chapter
  • First Online:
Cancer Metastasis Through the Lymphovascular System

Abstract

In this chapter we will describe the patterns of metastasis for two of the most common genitourinary malignancies, prostate cancer and bladder cancer. We will also discuss aspects of management for individuals with node-positive disease to provide insight into the clinical impact of metastasis on oncologic outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA: Cancer J Clin. 2021;71(4):359. First Published online: April 19, 2021. https://doi.org/10.3322/caac.21654.

  2. Fukuda H, Yamada T, Kamata S, Saitoh H. Anatomic distribution of intraprostatic lymphatics: implications for the lymphatic spread of prostate cancer – a preliminary study. Prostate. 2000;44:322–7. https://doi.org/10.1002/1097-0045(20000901)44:4<322::aid-pros9>3.0.co;2-8.

    Article  CAS  PubMed  Google Scholar 

  3. Rouviere H. Anatomy of the human lymphatic system. Ann Arbor. 1939;27:194–5. https://doi.org/10.1002/bjs.18002710531.

  4. Raghavaiah NV, Jordan WP. Prostatic lymphography. J Urol. 1979;121:178–81. https://doi.org/10.1016/s0022-5347(17)56712-9.

    Article  CAS  PubMed  Google Scholar 

  5. Brossner C, Ringhofer H, Hernady T, Kuber W, Madersbacher S, Pycha A. Lymphatic drainage of prostatic transition and peripheral zones visualized on a three-dimensional workstation. Urology. 2001;57:389–93. https://doi.org/10.1016/s0090-4295(00)00921-3.

    Article  CAS  PubMed  Google Scholar 

  6. Paganelli G, De Cicco C, Cremonesi M, et al. Optimized sentinel node scintigraphy in breast cancer. Q J Nucl Med. 1998;42:49–53.

    CAS  PubMed  Google Scholar 

  7. Nieweg OE, Tanis PJ, Kroon BB. The definition of a sentinel node. Ann Surg Oncol. 2001;8:538–41. https://doi.org/10.1007/s10434-001-0538-y.

    Article  CAS  PubMed  Google Scholar 

  8. Narayanan R, Wilson TG. Sentinel node evaluation in prostate cancer. Clin Exp Metastasis. 2018;35:471–85. https://doi.org/10.1007/s10585-018-9936-4.

    Article  PubMed  Google Scholar 

  9. Swanson GP, Hubbard JK. A better understanding of lymphatic drainage of the prostate with modern imaging and surgical techniques. Clin Genitourin Cancer. 2013;11:431–40. https://doi.org/10.1016/j.clgc.2013.04.031.

    Article  PubMed  Google Scholar 

  10. Saitoh H, Yoshida K-I, Uchijima Y, Kobayashi N, Suwata J, Kamata S. Two different lymph node metastatic patterns of a prostatic cancer. Cancer. 1990;65:1843–6. https://doi.org/10.1002/1097-0142(19900415)65:8<1843::aid-cncr2820650830>3.0.co;2-4.

    Article  CAS  PubMed  Google Scholar 

  11. Batson OV. The function of the vertebral veins and their role in the spread of metastases. Ann Surg. 1940;112:138–49. https://doi.org/10.1097/00000658-194007000-00016.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Bubendorf L, Schöpfer A, Wagner U, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;31:578–83. https://doi.org/10.1053/hp.2000.6698.

    Article  CAS  PubMed  Google Scholar 

  13. Tokuda Y, Carlino LJ, Gopalan A, et al. Prostate cancer topography and patterns of lymph node metastasis. Am J Surg Pathol. 2010;34:1862–7. https://doi.org/10.1097/PAS.0b013e3181fc679e.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Briganti A, Suardi N, Capogrosso P, et al. Lymphatic spread of nodal metastases in high-risk prostate cancer: the ascending pathway from the pelvis to the retroperitoneum. Prostate. 2012;72:186–92. https://doi.org/10.1002/pros.21420.

    Article  PubMed  Google Scholar 

  15. Nocera L, Sood A, Dalela D, et al. Rate and extent of pelvic lymph node dissection in the US prostate cancer patients treated with radical prostatectomy. Clin Genitourin Cancer. 2018;16:e451–67. https://doi.org/10.1016/j.clgc.2017.10.003.

    Article  PubMed  Google Scholar 

  16. Washington SL, Cowan JE, Herlemann A, et al. Influence of pelvic lymph node dissection and node-positive disease on biochemical recurrence, secondary treatment, and survival after radical prostatectomy in men with prostate cancer. Prostate. 2021;81:102–8. https://doi.org/10.1002/pros.24085.

    Article  CAS  PubMed  Google Scholar 

  17. Moris L, Van den Broeck T, Tosco L, et al. Impact of lymph node burden on survival of high-risk prostate cancer patients following radical prostatectomy and pelvic lymph node dissection. Front Surg. 2016;3:416–9. https://doi.org/10.3389/fsurg.2016.00065.

    Article  Google Scholar 

  18. Fossati N, Willemse P-PM, Van den Broeck T, et al. The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review. Eur Urol. 2017;72:84–109. https://doi.org/10.1016/j.eururo.2016.12.003.

    Article  PubMed  Google Scholar 

  19. Lestingi JFP, Guglielmetti GB, Trinh QD, et al. Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate- and high-risk prostate cancer: early oncological outcomes from a randomized phase 3 trial. Eur Urol. 2021;79:595–604. https://doi.org/10.1016/j.eururo.2020.11.040.

    Article  PubMed  Google Scholar 

  20. Cheng L, Weaver AL, Leibovich BC, et al. Predicting the survival of bladder carcinoma patients treated with radical cystectomy. Cancer. 2000;88:2326–32. https://doi.org/10.1002/(sici)1097-0142(20000515)88:10<2326::aid-cncr17>3.0.co;2-t.

    Article  CAS  PubMed  Google Scholar 

  21. Shinagare AB, Ramaiya NH, Jagannathan JP, Fennessy FM, Taplin ME, Van den Abbeele AD. Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor. AJR Am J Roentgenol. 2011;196:117–22. https://doi.org/10.2214/AJR.10.5036.

    Article  PubMed  Google Scholar 

  22. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19(3):666–75. https://doi.org/10.1200/JCO.2001.19.3.666. PMID: 11157016.

  23. Shariat SF, Karakiewicz PI, Palapattu GS, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium. J Urol. 2006;176:2414–22–discussion2422. https://doi.org/10.1016/j.juro.2006.08.004.

    Article  PubMed  Google Scholar 

  24. Roth B, Wissmeyer MP, Zehnder P, et al. A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol. 2010;57:205–11. https://doi.org/10.1016/j.eururo.2009.10.026.

    Article  PubMed  Google Scholar 

  25. Paño B, Sebastià C, Buñesch L, et al. Pathways of lymphatic spread in male urogenital pelvic malignancies. Radiographics. 2011;31:135–60. https://doi.org/10.1148/rg.311105072.

    Article  PubMed  Google Scholar 

  26. Paner GP, Stadler WM, Hansel DE, Montironi R, Lin DW, Amin MB. Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. Eur Urol. 2018;73:560–9. https://doi.org/10.1016/j.eururo.2017.12.018.

    Article  PubMed  Google Scholar 

  27. Horn T, Zahel T, Adt N, et al. Evaluation of computed tomography for lymph node staging in bladder cancer prior to radical cystectomy. Urol Int. 2016;96:51–6. https://doi.org/10.1159/000440889.

    Article  CAS  PubMed  Google Scholar 

  28. Ficarra V, Dalpiaz O, Alrabi N, Novara G, Galfano A, Artibani W. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int. 2005;95:786–90. https://doi.org/10.1111/j.1464-410X.2005.05401.x.

    Article  PubMed  Google Scholar 

  29. Salminen AP, Jambor I, Syvanen KT, Boström PJ. Update on novel imaging techniques for the detection of lymph node metastases in bladder cancer. Itali J Urol Nephrol. 2016;68:138–49.

    Google Scholar 

  30. Woo S, Suh CH, Kim SY, Cho JY, Kim SH. The diagnostic performance of MRI for detection of lymph node metastasis in bladder and prostate cancer: an updated systematic review and diagnostic meta-analysis. AJR Am J Roentgenol. 2018;210:W95–W109. https://doi.org/10.2214/AJR.17.18481.

    Article  PubMed  Google Scholar 

  31. Goodfellow H, Viney Z, Hughes P, et al. Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer. BJU Int. 2014;114:389–95.

    CAS  PubMed  Google Scholar 

  32. Soubra A, Hayward D, Dahm P, et al. The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis. World J Urol. 2016;34:1229–37. https://doi.org/10.1007/s00345-016-1772-z.

    Article  PubMed  Google Scholar 

  33. Jeong IG, Hong S, You D, Hong JH, Ahn H, Kim C-S. FDG PET-CT for lymph node staging of bladder cancer: a prospective study of patients with extended pelvic lymphadenectomy. Ann Surg Oncol. 2015;22:3150–6. https://doi.org/10.1245/s10434-015-4369-7.

    Article  PubMed  Google Scholar 

  34. Kim S-J, Koo PJ, Pak K, Kim I-J, Kim K. Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis. World J Urol. 2018;36:331–40. https://doi.org/10.1007/s00345-017-2168-4.

    Article  CAS  PubMed  Google Scholar 

  35. Birkhäuser FD, Studer UE, Froehlich JM, et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. Eur Urol. 2013;64:953–60. https://doi.org/10.1016/j.eururo.2013.07.032.

    Article  PubMed  Google Scholar 

  36. Zarifmahmoudi L, Ghorbani H, Sadri K, et al. Sentinel node biopsy in Urothelial carcinoma of the bladder: systematic review and meta-analysis. Urol Int. 2019;103:373–82. https://doi.org/10.1159/000497310.

    Article  PubMed  Google Scholar 

  37. Zarifmahmoudi L, Ghorbani H, Sadeghi R, et al. Sentinel lymph node biopsy in muscle-invasive bladder cancer: single-center experience. Ann Nucl Med. 2020;34:718–24. https://doi.org/10.1007/s12149-020-01502-6.

    Article  PubMed  Google Scholar 

  38. Watts KL, Ristau BT, Yamase HT, Taylor JA. Prognostic implications of lymph node involvement in bladder cancer: are we understaging using current methods? BJU Int. 2011;108:484–92. https://doi.org/10.1111/j.1464-410X.2011.10330.x.

    Article  PubMed  Google Scholar 

  39. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol. 2002;167:1295–8.

    Article  Google Scholar 

  40. Konety BR, Joslyn SA, O'Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the surveillance, epidemiology and end results program data base. J Urol. 2003;169:946–50. https://doi.org/10.1097/01.ju.0000052721.61645.a3.

    Article  PubMed  Google Scholar 

  41. Stein JP, Cai J, Groshen S, Skinner DG. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol. 2003;170:35–41. https://doi.org/10.1097/01.ju.0000072422.69286.0e.

    Article  PubMed  Google Scholar 

  42. Kassouf W, Agarwal PK, Herr HW, et al. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol. 2008;26:121–6. https://doi.org/10.1200/JCO.2007.12.9247.

    Article  PubMed  Google Scholar 

  43. Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol. 2008;179:873–8–discussion878. https://doi.org/10.1016/j.juro.2007.10.076.

    Article  Google Scholar 

  44. Leissner J, Ghoneim MA, Abol-Enein H, et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol. 2004;171:139–44. https://doi.org/10.1097/01.ju.0000102302.26806.fb.

    Article  CAS  PubMed  Google Scholar 

  45. Gschwend JE, Heck MM, Lehmann J, et al. Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective randomized trial. Eur Urol. 2019;75:604–11. https://doi.org/10.1016/j.eururo.2018.09.047.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of California, San Francisco, CA, USA

    Samuel L. Washington III, Peter R. Carroll & Sima P. Porten

Authors
  1. Samuel L. Washington III
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter R. Carroll
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sima P. Porten
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Samuel L. Washington III .

Editor information

Editors and Affiliations

  1. Department of Surgery and Melanoma Center, California Pacific Medical Center and Research Institute, San Francisco, CA, USA

    Stanley P. Leong

  2. Henry Ford Cancer Institute, Detroit, MI, USA

    S. David Nathanson

  3. Moffitt Cancer Center, Tampa, FL, USA

    Jonathan S. Zager

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Washington, S.L., Carroll, P.R., Porten, S.P. (2022). Urologic Cancer and the First Patterns of Metastasis. In: Leong, S.P., Nathanson, S.D., Zager, J.S. (eds) Cancer Metastasis Through the Lymphovascular System. Springer, Cham. https://doi.org/10.1007/978-3-030-93084-4_55

Download citation

Publish with us

Policies and ethics

Search

Navigation